ABCA7, BIN1, CD33, CLU, and CR1 expression levels were associated with clinical measures of AD (disease status, age at onset, disease duration, and/or CDR), and MS4A6A expression levels were associated with neuropathological measures of AD (Braak tangle and Braak plaque score). The gene discussed is CD33; the disease is Alzheimer disease.